Opportunity Information: Apply for CDC RFA PS12 1209PPHF12A
Apply for CDC RFA PS12 1209PPHF12A
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Viral Hepatitis, Early Identification and Linkage to Care for Persons with Chronic HBV and HCV Infections Financed in part by 2012 Prevention and Public Health Fund" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.270 Adult Viral Hepatitis Prevention and Control.
- This funding opportunity was created on Jun 13, 2013 and posted on Jun 13, 2013.
- Applicants must submit their applications by Jun 28, 2013 NO APPLICATIONS ARE BEING SOLICITED. THIS AMENDMENT IS FOR INFORMATIONAL PURPOSES ONLY REGARDING ADMINISTRATIVE CHANGES TO THE ORIGINAL FUNDING OPPORTUNITY. PLEASE SEE THE FULL ANNOUNCEMENT FOR THE UPDATES.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $6,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- The number of recipients for this funding is limited to 42 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible applicants under Category A Early Identification and Linkage to Care for Foreign born Persons with Hepatitis B, are serving populations of the cities with the highest number of foreign born persons from Asia and Africa as documented in the 2006 2010 American Community Survey. These 50 eligible geographic areas/cities combined contain approximately 12.5 of the total US population and approximately 33 of the Asia born population, 28 of the Africa born population, and 32 of the combined Asia and Africa born population. The full listing of eligible applicants by City and state is available in the full announcement document under Section III. Eligible applicants under Category B All Parts (1, 2a, 2b, and 3) are Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals CBOs Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a Bona Fide Agent of an eligible state, local, or territorial government, a Memorandum of Agreement (MOA) with the eligible state or local government is required as documentation of the status and must be submitted with the application. At a minimum, the MOA must include the following roles and responsibilities of the state or local government agency roles and responsibilities of the Bona Fide Agent key personnel contacts for the state or local government agency and key personnel contacts for the Bona Fide Agent.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, issued by the Centers for Disease Control and Prevention (CDC) under Funding Opportunity Number CDC RFA PS12-1209PPHF12A, was designed to expand viral hepatitis testing and strengthen the path from diagnosis to medical care for people living with chronic hepatitis B (HBV) and hepatitis C (HCV). The core aim was early identification of infections, particularly among medically underserved communities and groups that experience a disproportionate burden of HBV and HCV. In practical terms, the initiative emphasized finding people who are infected but unaware, making sure they are informed of their status, providing appropriate counseling, and ensuring they are successfully linked to clinical care, treatment, and prevention services. The opportunity explicitly aligns with the HHS Viral Hepatitis Action Plan and supports Healthy People 2020 priorities within Immunization and Infectious Diseases, reflecting a broader federal strategy to reduce transmission, complications, and long-term health impacts associated with viral hepatitis.
The award mechanism for this opportunity was a cooperative agreement, meaning CDC would typically have substantial involvement beyond simply providing funds, often through program guidance, oversight, or technical assistance. The activity category was health, and the CFDA number listed was 93.270 (Adult Viral Hepatitis Prevention and Control). The announcement projected up to 42 awards with an estimated total funding amount of $6.5 million. Individual awards were expected to range from a floor of $300,000 to a ceiling of $1,500,000. Importantly, there was no cost sharing or matching requirement stated, which generally lowers the barrier for eligible organizations that may not have substantial non-federal resources to contribute.
A notable part of the eligibility structure was that it was divided into categories with different requirements. Under Category A, the focus was early identification and linkage to care for foreign-born persons with hepatitis B, specifically in cities with the highest numbers of foreign-born residents from Asia and Africa based on the 2006-2010 American Community Survey. The eligible geographic areas were limited to 50 cities/areas identified in the full announcement, and the CDC highlighted why: these locations collectively represented about 12.5 percent of the US population but included a much larger share of Asia-born and Africa-born residents (roughly one-third of the Asia-born population and over one-quarter of the Africa-born population), which corresponds to communities where chronic HBV prevalence can be higher due to global epidemiology and historical differences in vaccination coverage and perinatal transmission prevention.
Category B had broader eligibility across all parts of the program and included a wide range of applicant types. Eligible entities included nonprofits with or without 501(c)(3) status (excluding institutions of higher education in that specific nonprofit line item), for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based organizations, faith-based organizations, tribal governments and tribally designated organizations (including Alaska Native health corporations, urban Indian health organizations, and tribal epidemiology centers), and state, local, territorial, and freely associated state governments and their political subdivisions. The announcement also allowed applications from a Bona Fide Agent acting on behalf of an eligible government entity, but required documentation through a Memorandum of Agreement. That MOA had to spell out roles and responsibilities for both the government entity and the agent, along with key personnel contacts on each side, which is a common federal grants safeguard to ensure clear accountability and authority to apply.
Although the program’s public health goals were clear and the funding levels substantial, the notice provided here also makes clear that, as of the amendment referenced in the posting, no applications were being solicited. The original posting date and creation date were June 13, 2013, with an original (and current) closing date of June 28, 2013, and an archive date of July 28, 2013. The announcement text states that the amendment was for informational purposes only and related to administrative changes to the original funding opportunity, directing readers to consult the full announcement for updates. In other words, the listing is best understood as an archived federal funding notice describing a past competition and its administrative updates, rather than an open call for new applications.
For applicants and stakeholders looking at this opportunity as a model, the central program concept was straightforward: improve hepatitis outcomes by building or expanding testing initiatives and then closing the gap between diagnosis and care. That includes not just performing tests, but also ensuring that people who test positive are notified, counseled, and effectively connected to medical evaluation and ongoing care, while also delivering prevention services aimed at reducing onward transmission and preventing new cases. The CDC provided contact information through its Procurement and Grants Office Technical Information Management Section for those who had difficulty accessing the full announcement materials.
Frequently Asked Questions (FAQs)
What is this CDC grant opportunity?
This funding opportunity was issued by the Centers for Disease Control and Prevention (CDC) as Funding Opportunity Number CDC RFA PS12-1209PPHF12A. It focused on expanding viral hepatitis testing and strengthening the pathway from diagnosis to medical care for people living with chronic hepatitis B (HBV) and hepatitis C (HCV).
What public health problem was this grant designed to address?
The program aimed to improve early identification of HBV and HCV infections, especially among medically underserved communities and groups that experience a disproportionate burden of these infections. A practical priority was finding people who are infected but unaware, informing them of their status, providing appropriate counseling, and ensuring successful linkage to clinical care, treatment, and prevention services.
What were the main goals or activities emphasized by the program?
Based on the notice, the emphasized activities included: (1) increasing HBV/HCV testing to identify infections earlier, (2) ensuring people who test positive are notified and informed of their status, (3) providing counseling, and (4) strengthening linkage to clinical care, treatment, and prevention services so that diagnosis leads to real, ongoing medical follow-up and reduced transmission risk.
How does this opportunity align with broader federal health strategies?
The opportunity explicitly aligned with the HHS Viral Hepatitis Action Plan and supported Healthy People 2020 priorities within Immunization and Infectious Diseases. The overall intent was consistent with reducing transmission, complications, and long-term health impacts associated with viral hepatitis.
What type of award was this?
The award mechanism was a cooperative agreement. That generally indicates CDC would typically have substantial involvement beyond providing funds, such as program guidance, oversight, and/or technical assistance.
What was the activity category and CFDA number?
The activity category was health. The CFDA number listed was 93.270 (Adult Viral Hepatitis Prevention and Control).
How much funding was expected to be available?
The announcement projected an estimated total funding amount of $6.5 million.
How many awards were anticipated?
The notice projected up to 42 awards.
What was the expected award size per recipient?
Individual awards were expected to range from a floor of $300,000 to a ceiling of $1,500,000.
Was cost sharing or matching required?
No cost sharing or matching requirement was stated in the notice.
Who was the program intended to serve or prioritize?
The program prioritized early identification of HBV and HCV infections, particularly among medically underserved communities and populations with a disproportionate burden of chronic hepatitis B and hepatitis C. The practical emphasis was on people who are infected but unaware, and ensuring they are connected to appropriate care and prevention services after diagnosis.
How was eligibility structured in this opportunity?
Eligibility was divided into categories with different requirements, including Category A and Category B.
What was Category A focused on?
Category A focused on early identification and linkage to care for foreign-born persons with hepatitis B, specifically in cities with the highest numbers of foreign-born residents from Asia and Africa, based on the 2006-2010 American Community Survey.
Were there geographic limits under Category A?
Yes. Category A eligibility was limited to 50 cities/areas identified in the full announcement. The CDC rationale noted these locations represented about 12.5 percent of the US population but included roughly one-third of the Asia-born population and over one-quarter of the Africa-born population.
Why did Category A emphasize foreign-born residents from Asia and Africa?
The notice indicated these communities can have higher chronic HBV prevalence due to global epidemiology and historical differences in vaccination coverage and perinatal transmission prevention.
What was Category B and how was it different from Category A?
Category B had broader eligibility across all parts of the program and included a wide range of applicant types, rather than being limited to the specific Category A geographic areas and population focus described in the notice.
What types of organizations were eligible under Category B?
Eligible entities listed included: nonprofits with or without 501(c)(3) status (excluding institutions of higher education in that specific nonprofit line item), for-profit organizations (including small, minority-, and women-owned businesses), universities and colleges, research institutions, hospitals, community-based organizations, faith-based organizations, tribal governments and tribally designated organizations (including Alaska Native health corporations, urban Indian health organizations, and tribal epidemiology centers), and state, local, territorial, and freely associated state governments and their political subdivisions.
Could a Bona Fide Agent apply on behalf of a government entity?
Yes. The announcement allowed applications from a Bona Fide Agent acting on behalf of an eligible government entity, but required documentation through a Memorandum of Agreement (MOA).
What needed to be included in the Memorandum of Agreement (MOA) for a Bona Fide Agent application?
The MOA had to spell out roles and responsibilities for both the government entity and the agent, along with key personnel contacts on each side. This was described as a safeguard to ensure clear accountability and authority to apply.
Is this funding opportunity currently open for applications?
No. The notice stated that, as of the amendment referenced in the posting, no applications were being solicited. It is best understood as an archived federal funding notice describing a past competition and related administrative updates rather than an open call.
What were the key dates listed in the notice?
The original posting date and creation date were June 13, 2013. The original (and current) closing date was June 28, 2013. The archive date was July 28, 2013.
What did the amendment mentioned in the notice do?
The notice stated the amendment was for informational purposes only and related to administrative changes to the original funding opportunity. It directed readers to consult the full announcement for updates.
What is the central program concept described by the notice?
The central concept was to improve hepatitis outcomes by building or expanding testing initiatives and closing the gap between diagnosis and care. That includes testing, notifying people of results, counseling, linking people who test positive to medical evaluation and ongoing care, and delivering prevention services aimed at reducing onward transmission and preventing new cases.
Who should be contacted if someone had difficulty accessing the full announcement materials?
The notice stated that CDC provided contact information through its Procurement and Grants Office Technical Information Management Section for those who had difficulty accessing the full announcement materials.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Rapid Secondary Analysis to Optimize Care for Patients with Multiple Chronic Conditions (R01)
Previous opportunity: (RFI) Manufacturing Barriers and Opportunities for Water Power Technologies
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS12 1209PPHF12A
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS12 1209PPHF12A) also looked into and applied for these:
| Funding Opportunity |
|---|
| Rapid Secondary Analysis to Optimize Care for Patients with Multiple Chronic Conditions (R01) Apply for RFA HS 14 001 Funding Number: RFA HS 14 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $400,000 |
| Improving Sexually Transmitted Disease Programs through Assessment, Assurance, Policy Development, and Prevention Strategies (STD AAPPS) Apply for CDC RFA PS14 1402 Funding Number: CDC RFA PS14 1402 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $7,276,076 |
| Addressing Methodological Challenges in Research for Patients with Multiple Chronic Conditions (R21) Apply for RFA HS 14 002 Funding Number: RFA HS 14 002 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $180,000 |
| Viral Hepatitis, Early Identification and Linkage to Care for Persons with Chronic HBV and HCV Infections Apply for CDC RFA PS12 120901SUPP13 Funding Number: CDC RFA PS12 120901SUPP13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| The Disability and Rehabilitation Research and Training Program Rehabilitation Research and Training Centers RRTCs) Promoting Healthy Aging for Individuals with Long Term Physical Disabilities CFDA Number 84.133B 10 Apply for IVV R1230 OPP1 06162013 Funding Number: IVV R1230 OPP1 06162013 Agency: IVV Test Agency Category: Health Funding Amount: $1,000 |
| NIBIB Biomedical Technology Service Centers (P30) Apply for PAR 13 249 Funding Number: PAR 13 249 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| State Protection and Advocacy Traumatic Brain Injury Program (PATBI) Apply for HRSA 14 004 Funding Number: HRSA 14 004 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| PPHF 2013 Prevention Research Centers Health Promotion and Disease Prevention Research Centers financed in part by 2013 Prevention and Public Health Funds Apply for RFA DP 09 001PPHF13 Funding Number: RFA DP 09 001PPHF13 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Global Partnerships for Cancer Prevention and Control Apply for CDC RFA DP13 1312 Funding Number: CDC RFA DP13 1312 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Mentored Career Development Award to Build Research Capacity in Global Mental Health (K01) Apply for RFA MH 14 120 Funding Number: RFA MH 14 120 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of the National Violent Death Reporting System (NVDRS) CDC RFA CE09 904 Apply for CDC RFA CE13 1312 Funding Number: CDC RFA CE13 1312 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $255,000 |
| NIMHD Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42) Apply for RFA MD 13 009 Funding Number: RFA MD 13 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maintaining Collection of National Violent Death Reporting System (NVDRS) Data CDC RFA CE08 802 Apply for CDC RFA CE13 1311 Funding Number: CDC RFA CE13 1311 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $240,000 |
| Maintaining Collection of National Violent Death Reporting System (NVDRS) Data CDC RFA CE07 704 Apply for CDC RFA CE13 1310 Funding Number: CDC RFA CE13 1310 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $235,000 |
| Local Partners for Orphans and Vulnerable Children Project Apply for RFA 620 13 000004 Funding Number: RFA 620 13 000004 Agency: Nigeria USAID Abuja Category: Health Funding Amount: $32,500,000 |
| Drug Docking and Screening Data Resource (U01) Apply for RFA GM 14 010 Funding Number: RFA GM 14 010 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| HIV Care Grant Program Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Awards Apply for HRSA 13 202 Funding Number: HRSA 13 202 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Tobacco Control Regulatory Research (R21) Apply for RFA OD 13 010 Funding Number: RFA OD 13 010 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Tobacco Control Regulatory Research (R01) Apply for RFA OD 13 011 Funding Number: RFA OD 13 011 Agency: National Institutes of Health Category: Health Funding Amount: $499,999 |
| Tobacco Control Regulatory Research (R03) Apply for RFA OD 13 012 Funding Number: RFA OD 13 012 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS12 1209PPHF12A", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.